Life-Sciences-France.com
The French Life Sciences Web Portal

This is a free web portal for the life sciences in France and Monaco... » read more

Earendil Labs Licenses Antibodies to Sanofi for up to $1.85b (2025-04-17)
Earendil Labs, a global leader in AI-driven research and development of next-generation biologics therapeutics, and Sanofi today announced that they have entered into a license agreement for two potential first-in-class bispecific antibodies in the field of autoimm...
Glycomine Announces $115m Series C Financing Round (2025-04-16)
> GLM101 is the first disease-modifying therapeutic in development to treat PMM2-CDG, the most common congenital disorder of glycosylation > Data from the ongoing Phase 2 open-label study of GLM101 provide clinical proof of concept, showing improvement in ataxia...
CDMO Meribel Pharma Launches Backed by Blue Wolf Capital (2025-04-15)
A new, mid-size Contract Development Manufacturing Organisation (CDMO), Meribel Pharma Solutions has launched today with an extensive integrated network across Europe, led by a team of industry experts on a mission to deliver the highest quality solutions and servi...
Nuage Therapeutics Appoints New CEO and New Board Chair (2025-04-01)
> Experienced R&D leader and biotech entrepreneur, Stuart Hughes, appointed as Chief Executive Officer > Life sciences executive and healthcare investor, Vanessa Malier, appointed as Chair of the Board of Directors > Nuage Therapeutics applying its proprietar...
Augustine Adds €60.2m to Close Series A at Total of €77.7m (2025-03-24)
> Novo Holdings and Jeito Capital co-led the deal, supported by Asabys Partners and existing investors > Proceeds to support the clinical development of lead candidate AGT-100216 for the treatment of Charcot-Marie-Tooth (CMT) disease, with Phase I trials startin...
Allogenica Secures €2.5m Grant from French Government (2025-03-19)
> Allogenica received a €2.5 million grant from the French government's France 2030 program to support the industrialization of its breakthrough universal CAR-T therapies for blood cancers. > Cost-effective, scalable CAR-T solutions: Allogenica, using its prop...
Forth Therapeutics Launches Backed by Sofinnova & OCC (2025-03-18)
> Cutting-edge research from Professor Neil Henderson at the University of Edinburgh > Led by CEO Alex Leech, Partner at Sofinnova Partners > Created through Sofinnova’s €165M Biovelocita II, biotech fund Forth Therapeutics (Forth Tx), a biotechnolog...
BioClec Launches with Backing from Sofinnova Partners (2025-03-18)
> Co-founded by Dr. Marco Colonna, a global expert in neuroimmunology and Alzheimer's research > Led by CEO Gabriella Camboni, an eminent serial entrepreneur with a track record of successful biotech ventures BioClec, a cutting-edge biotechnology company fo...
Final Close of Sofinnova Biovelocita II Fund at €165m (2025-03-18)
> Biovelocita II attracts robust support from leading pharmaceutical companies, including Amgen, Bristol Myers Squibb, and Pfizer Ventures > The fund has already screened over 300 projects and made several investments into new companies to catalyze transformativ...
[iito] Announces Major Changes in Its Social Media Strategy (2025-03-18)
> [iito] ceased all activities on Twitter/X in 2023 > All social media activities today focussed on LinkedIn > Planning for a future outside of the “big” social media platforms [iito] Business Intelligence – a Germany-based business intelligence p...

Life-Sciences-France.com is your doorway to the French life sciences!

[LSF] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in France and Monaco.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSF] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group ChinaBio Partnering Forum 2025 Shanghai 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)